Capricor Therapeutics (NASDAQ:CAPR – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research report issued to clients and investors on Thursday,Benzinga reports. They presently have a $77.00 target price on the biotechnology company’s stock. HC Wainwright’s price target suggests a potential upside of 301.46% from the […]

Bitfarms (NASDAQ:BITF – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at HC Wainwright in a research report issued on Thursday,Benzinga reports. They currently have a $4.00 price target on the stock. HC Wainwright’s price target suggests a potential upside of 76.60% from the stock’s current price. Separately, Cantor Fitzgerald reiterated […]

Fulcrum Therapeutics (NASDAQ:FULC – Get Free Report)‘s stock had its “neutral” rating reissued by research analysts at HC Wainwright in a report released on Thursday,Benzinga reports. They currently have a $4.00 target price on the stock. HC Wainwright’s price target would suggest a potential upside of 12.36% from the stock’s current price. Several other research […]

HC Wainwright reiterated their neutral rating on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) in a research note published on Wednesday morning,Benzinga reports. They currently have a $1.00 target price on the stock, down from their prior target price of $6.00. Several other equities analysts also recently commented on SYRS. TD Cowen restated a […]

HC Wainwright restated their buy rating on shares of Delcath Systems (NASDAQ:DCTH – Free Report) in a research report released on Monday morning,Benzinga reports. They currently have a $22.00 target price on the stock. Several other research firms have also issued reports on DCTH. Stephens restated a “buy” rating on shares of Delcath Systems in […]

HC Wainwright reaffirmed their buy rating on shares of Janux Therapeutics (NASDAQ:JANX – Free Report) in a research report report published on Thursday morning,Benzinga reports. They currently have a $63.00 price objective on the stock. A number of other equities research analysts have also issued reports on the stock. UBS Group assumed coverage on shares […]

Solid Biosciences (NASDAQ:SLDB – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a research note issued on Thursday,Benzinga reports. They presently have a $16.00 price objective on the stock. HC Wainwright’s target price would suggest a potential upside of 172.57% from the company’s previous close. Several other equities analysts have […]

HC Wainwright reiterated their buy rating on shares of Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) in a report issued on Wednesday,Benzinga reports. They currently have a $11.00 price target on the stock. HC Wainwright also issued estimates for Black Diamond Therapeutics’ Q4 2024 earnings at ($0.31) EPS, FY2024 earnings at ($1.29) EPS, Q1 2025 […]

HC Wainwright reaffirmed their buy rating on shares of BigBear.ai (NYSE:BBAI – Free Report) in a research note issued to investors on Wednesday morning,Benzinga reports. They currently have a $3.00 price objective on the stock. HC Wainwright also issued estimates for BigBear.ai’s Q4 2024 earnings at ($0.04) EPS, FY2024 earnings at ($0.22) EPS and FY2025 […]